-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to implement the clinical value-oriented and patient-centered R&D concept, and promote the scientific and orderly development of anti-tumor drugs, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation has organized and formulated the "Clinical Value-Oriented Anti-tumor Drugs" Guidelines for Clinical Research and Development of Tumor Drugs (see appendix)
.
In accordance with the requirements of the "Notice of the Comprehensive Department of the State Drug Administration on Issuing the Procedures for Issuing the Technical Guidelines for Drugs" (Yao Jian Zong Yao Guan [2020] No.
Hereby inform
.
Attachment: Guiding Principles for Clinical Research and Development of Anti-tumor Drugs Oriented by Clinical Value
National Food and Drug Administration Center for Drug Evaluation
November 15, 2021
The "Clinical Value-Oriented Guiding Principles for the Clinical Research and Development of Anti-tumor Drugs" is released.
Once the guidelines are published, many "Chinese->
.
It also shows that the next step for the pharmaceutical industry to move towards the field of innovation, FIC will be increasingly valued and tilted by capital